2019
DOI: 10.1038/s41551-019-0381-8
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of three congruent patient-specific cell types for the modelling of a human genetic Schwann-cell disorder

Abstract: Patient-specific human induced pluripotent stem cells (hiPSCs) hold great promise for the modelling of genetic disorders. However, these cells display wide intra-individual and inter-individual variations in gene expression, making it challenging to distinguish true-positive and false-positive phenotypes. Also, data from hiPSC phenotypes and from human embryonic stem cells (hESCs) harbouring the same disease mutation are lacking. Here, we report a comparison of molecular, cellular and functional characteristic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
53
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 25 publications
(53 citation statements)
references
References 48 publications
0
53
0
Order By: Relevance
“…Furthermore, the inhibition of NOTCH signaling abolished the effect of TGFβ ( Figure 4 b,c,g,h), indicating that the myotube generating process is a target regulated by the combinatorial mechanism of TGFβ and NOTCH [ 22 ]. To corroborate the effect of the combinational inhibition of TGFβ and NOTCH on the promotion of myotube formation, we employed human primary myoblasts, another model system that could rule out biological or technical errors in studies with iPSCs [ 31 ]. The promotion of myotube formation by combinational inhibition of TGFβ and NOTCH was reproduced in the primary myoblasts-based experiment ( Figure 5 a–c), and furthermore, the effect on myotube formation was also demonstrated in iPSC-derived myoblasts from DMD patients ( Figure 5 f–j).…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, the inhibition of NOTCH signaling abolished the effect of TGFβ ( Figure 4 b,c,g,h), indicating that the myotube generating process is a target regulated by the combinatorial mechanism of TGFβ and NOTCH [ 22 ]. To corroborate the effect of the combinational inhibition of TGFβ and NOTCH on the promotion of myotube formation, we employed human primary myoblasts, another model system that could rule out biological or technical errors in studies with iPSCs [ 31 ]. The promotion of myotube formation by combinational inhibition of TGFβ and NOTCH was reproduced in the primary myoblasts-based experiment ( Figure 5 a–c), and furthermore, the effect on myotube formation was also demonstrated in iPSC-derived myoblasts from DMD patients ( Figure 5 f–j).…”
Section: Discussionmentioning
confidence: 99%
“…This method shortened the total differentiation time from approximately 41 days ( Huang et al, 2017 ) to approximately 32 days ( Kim et al, 2017 ). However, a more recent protocol has been developed for the derivation of direct Schwann-cell precursors (SCPs) from SOX10-reporting hiPSCs that only required a total differentiation time of 21 days and allowed for in vitro culture up to 80 days with maintained expression of the SC proteins S100b, glial fibrillary acidic protein (GFAP), and galactosylceramidase ( Mukherjee-Clavin et al, 2019 ). With all these methods, differentiated SCs show increased expression of SC-specific markers such as GFAP and S100β.…”
Section: Developmentmentioning
confidence: 99%
“…Differentiation protocols and analysis of myelinating cells were described in [48]. The image of iSCs was kindly provided by Dr. Yong Jun Kim [49].…”
Section: Scs With Neurons and The Dependency On Axon Contact For Sc Ementioning
confidence: 99%
“…The concept of SC creation is rather new [56]. In this paradigm, cells with SC characteristics (iSCs) are derived by using directed in vitro differentiation (e.g., from multipotent neural or non-neural stem cells) [57], transdifferentiation [56] or even direct conversion from somatic cells such as fibroblasts [49,58]. iSCs can be generated from embryonic stem cells, induced pluripotent stem cells (iPSCs), [59], neural stem cells (e.g., neural crest-derived) and mesenchymal stem cells (MSCs) originating from the bone marrow [60][61][62] or adipose tissue [63].…”
Section: Iscs and The Advent Of Technologies To Recreate The Sc Phenomentioning
confidence: 99%
See 1 more Smart Citation